Deficiency of phospholipase A2 receptor exacerbates ovalbumin-induced lung inflammation

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1021-1028

  Tamaru, Shun ^a   Mishina, Hideto ^a   Watanabe, Yosuke ^a   Watanabe, Kazuhiro ^a   Fujioka, Daisuke ^a   Takahashi, Soichiro ^a   Suzuki, Koji ^a   Nakamura, Takamitsu ^a   Obata, Jun Ei ^a   Kawabata, Kenichi ^a   Yokota, Yasunori ^b   Murakami, Makoto ^c   Hanasaki, Kohji ^b   Kugiyama, Kiyotaka ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ICOSANOID; PHOSPHOLIPASE A2 RECEPTOR; OVALBUMIN; PHOSPHOLIPASE A2 GROUP IB; PHOSPHOLIPASE A2 GROUP X; PLA2G10 PROTEIN, MOUSE; PLA2G1B PROTEIN, MOUSE;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME DEGRADATION; EOSINOPHIL; FEMALE; INFLAMMATORY CELL; LUNG CLEARANCE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; LUNG LAVAGE; METABOLISM;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; EICOSANOIDS; EOSINOPHILS; FEMALE; GROUP IB PHOSPHOLIPASES A2; GROUP X PHOSPHOLIPASES A2; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; OVALBUMIN; PNEUMONIA; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84880688864     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300738     Document Type: Article

References (37)

1. Matsuoka, T., M. Hirata, H. Tanaka, Y. Takahashi, T. Murata, K. Kabashima, Y. Sugimoto, T. Kobayashi, F. Ushikubi, Y. Aze, et al. 2000. Prostaglandin D2 as a mediator of allergic asthma. Science 287: 2013-2017.
2. Terawaki, K., T. Yokomizo, T. Nagase, A. Toda, M. Taniguchi, K. Hashizume, T. Yagi, and T. Shimizu. 2005. Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J. Immunol. 175: 4217-4225.
3. Tager, A. M., S. K. Bromley, B. D. Medoff, S. A. Islam, S. D. Bercury, E. B. Friedrich, A. D. Carafone, R. E. Gerszten, and A. D. Luster. 2003. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4: 982-990.
4. Hallstrand, T. S., and W. R. Henderson, Jr. 2010. An update on the role of leukotrienes in asthma. Curr. Opin. Allergy Clin. Immunol. 10: 60-66.
5. Balestrieri, B., and J. P. Arm. 2006. Group V sPLA2: classical and novel functions. Biochim. Biophys. Acta 1761: 1280-1288.
6. Murakami, M., Y. Taketomi, C. Girard, K. Yamamoto, and G. Lambeau. 2010. Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice. Biochimie 92: 561-582.
7. Boyanovsky, B. B., and N. R. Webb. 2009. Biology of secretory phospholipase A2. Cardiovasc. Drugs Ther. 23: 61-72.
8. Balsinde, J., M. V. Winstead, and E. A. Dennis. 2002. Phospholipase A(2) regulation of arachidonic acid mobilization. FEBS Lett. 531: 2-6.
9. Kita, Y., T. Ohto, N. Uozumi, and T. Shimizu. 2006. Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s. Biochim. Biophys. Acta 1761: 1317-1322.
10. Hanasaki, K. 2004. Mammalian phospholipase A2: phospholipase A2 receptor. Biol. Pharm. Bull. 27: 1165-1167.
11. Hallstrand, T. S., E. Y. Chi, A. G. Singer, M. H. Gelb, and W. R. Henderson, Jr. 2007. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 176: 1072-1078.
12. Henderson, W. R., Jr., E. Y. Chi, J. G. Bollinger, Y. T. Tien, X. Ye, L. Castelli, Y. P. Rubtsov, A. G. Singer, G. K. Chiang, T. Nevalainen, et al. 2007. Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J. Exp. Med. 204: 865-877.
13. Munoz, N. M., A. Y. Meliton, J. P. Arm, J. V. Bonventre,W. Cho, and A. R. Leff. 2007. Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J. Immunol. 179: 4800-4807.
14. Uozumi, N., K. Kume, T. Nagase, N. Nakatani, S. Ishii, F. Tashiro, Y. Komagata, K. Maki, K. Ikuta, Y. Ouchi, et al. 1997. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390: 618-622.
15. Triggiani, M., F. Granata, G. Giannattasio, and G. Marone. 2005. Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. J. Allergy Clin. Immunol. 116: 1000-1006.
16. Valentin, E., and G. Lambeau. 2000. Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. Biochim. Biophys. Acta 1488: 59-70.
17. Ishizaki, J., K. Hanasaki, K. Higashino, J. Kishino, N. Kikuchi, O. Ohara, and H. Arita. 1994. Molecular cloning of pancreatic group I phospholipase A2 receptor. J. Biol. Chem. 269: 5897-5904.
18. Hanasaki, K., and H. Arita. 2002. Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. Prostaglandins Other Lipid Mediat. 68-69: 71-82.
19. Rouault, M., C. Le Calvez, E. Boilard, F. Surrel, A. Singer, F. Ghomashchi, S. Bezzine, S. Scarzello, J. Bollinger, M. H. Gelb, and G. Lambeau. 2007. Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. Biochemistry 46: 1647-1662.
20. East, L., and C. M. Isacke. 2002. The mannose receptor family. Biochim. Biophys. Acta 1572: 364-386.
21. Zvaritch, E., G. Lambeau, and M. Lazdunski. 1996. Endocytic properties of the M-type 180-kDa receptor for secretory phospholipases A2. J. Biol. Chem. 271: 250-257.
22. Yokota, Y., M. Notoya, K. Higashino, Y. Ishimoto, K. Nakano, H. Arita, and K. Hanasaki. 2001. Clearance of group X secretory phospholipase A(2) via mouse phospholipase A(2) receptor. FEBS Lett. 509: 250-254.
23. Sato, R., S. Yamaga, K. Watanabe, S. Hishiyama, K. Kawabata, T. Kobayashi, D. Fujioka, Y. Saito, T. Yano, K. Watanabe, et al. 2010. Inhibition of secretory phospholipase A2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model. Exp. Lung Res. 36: 191-200.
24. Kanemasa, T., A. Arimura, J. Kishino, M. Ohtani, and H. Arita. 1992. Contraction of guinea pig lung parenchyma by pancreatic type phospholipase A2 via its specific binding site. FEBS Lett. 303: 217-220.
25. Yokota, Y., M. Ikeda, K. Higashino, K. Nakano, N. Fujii, H. Arita, and K. Hanasaki. 2000. Enhanced tissue expression and elevated circulating level of phospholipase A(2) receptor during murine endotoxic shock. Arch. Biochem. Biophys. 379: 7-17.
26. Hanasaki, K., Y. Yokota, J. Ishizaki, T. Itoh, and H. Arita. 1997. Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice. J. Biol. Chem. 272: 32792-32797.
27. Enomoto, A., M. Murakami, and I. Kudo. 2000. Internalization and degradation of type IIA phospholipase A(2) in mast cells. Biochem. Biophys. Res. Commun. 276: 667-672.
28. Chung, K. F. 2000. Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation? Eur. Respir. J. 15: 961-968.
29. Suzuki, N., J. Ishizaki, Y. Yokota, K. Higashino, T. Ono, M. Ikeda, N. Fujii, K. Kawamoto, and K. Hanasaki. 2000. Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s. J. Biol. Chem. 275: 5785-5793.
30. Kennedy, B. P., P. Payette, J. Mudgett, P. Vadas, W. Pruzanski, M. Kwan, C. Tang, D. E. Rancourt, and W. A. Cromlish. 1995. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J. Biol. Chem. 270: 22378-22385.
31. Beck, L. H., Jr., R. G. Bonegio, G. Lambeau, D. M. Beck, D. W. Powell, T. D. Cummins, J. B. Klein, and D. J. Salant. 2009. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361: 11-21.
32. Higashino Ki, K., Y. Yokota, T. Ono, S. Kamitani, H. Arita, and K. Hanasaki. 2002. Identification of a soluble form phospholipase A2 receptor as a circulating endogenous inhibitor for secretory phospholipase A2. J. Biol. Chem. 277: 13583-13588.
33. Mandal, A. K., Z. Zhang, J. Y. Chou, and A. B. Mukherjee. 2001. Pancreatic phospholipase A2 via its receptor regulates expression of key enzymes of phospholipid and sphingolipid metabolism. FASEB J. 15: 1834-1836.
34. Granata, F., A. Petraroli, E. Boilard, S. Bezzine, J. Bollinger, L. Del Vecchio, M. H. Gelb, G. Lambeau, G. Marone, and M. Triggiani. 2005. Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor. J. Immunol. 174: 464-474.
35. Han, W. K., A. Sapirstein, C. C. Hung, A. Alessandrini, and J. V. Bonventre. 2003. Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid release. J. Biol. Chem. 278: 24153-24163.
36. Yano, T., D. Fujioka, Y. Saito, T. Kobayashi, T. Nakamura, J. E. Obata, K. Kawabata, K. Watanabe, Y. Watanabe, H. Mishina, et al. 2011. Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemiareperfusion injury. Cardiovasc. Res. 90: 335-343.
37. Fonteh, A. N., G. Atsumi, T. LaPorte, and F. H. Chilton. 2000. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells. J. Immunol. 165: 2773-2782.